68 related articles for article (PubMed ID: 27435393)
21. CCAAT/Enhancer-Binding Protein Delta Regulates Glioblastoma Survival through Catalase-Mediated Hydrogen Peroxide Clearance.
Lin HY; Lim SW; Hsu TI; Yang WB; Huang CC; Tsai YT; Chang WC; Ko CY
Oxid Med Cell Longev; 2022; 2022():4081380. PubMed ID: 36035213
[TBL] [Abstract][Full Text] [Related]
22. Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives.
Liu S; Chen X; Lin T
J Adv Res; 2022 Jul; 39():187-202. PubMed ID: 35777908
[TBL] [Abstract][Full Text] [Related]
23. Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study.
Koguchi D; Matsumoto K; Ikeda M; Taoka Y; Hirayama T; Murakami Y; Utsunomiya T; Matsuda D; Okuno N; Irie A; Iwamura M
BMC Urol; 2022 May; 22(1):75. PubMed ID: 35549909
[TBL] [Abstract][Full Text] [Related]
24. SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.
Zhou Z; Zhang Z; Chen H; Bao W; Kuang X; Zhou P; Gao Z; Li D; Xie X; Yang C; Chen X; Pan J; Tang R; Feng Z; Zhou L; Wang L; Yang J; Jiang L
Br J Cancer; 2022 Jul; 127(2):211-222. PubMed ID: 35484216
[TBL] [Abstract][Full Text] [Related]
25. FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
Lu YT; Xu T; Iqbal M; Hsieh TC; Luo Z; Liang G; Farnham PJ; Rhie SK; Goldkorn A
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406487
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
Chan TC; Hsing CH; Shiue YL; Huang SK; Hsieh KL; Kuo YH; Li CF
Cells; 2022 Feb; 11(4):. PubMed ID: 35203290
[TBL] [Abstract][Full Text] [Related]
27. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers.
Hsiao YW; Chi JY; Li CF; Chen LY; Chen YT; Liang HY; Lo YC; Hong JY; Chuu CP; Hung LY; Du JY; Chang WC; Wang JM
Clin Transl Med; 2022 Jan; 12(1):e724. PubMed ID: 35090088
[TBL] [Abstract][Full Text] [Related]
28. BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway.
Jiang N; Liao Y; Wang M; Wang Y; Wang K; Guo J; Wu P; Zhong B; Guo T; Wu C
J Exp Clin Cancer Res; 2021 Dec; 40(1):378. PubMed ID: 34852826
[TBL] [Abstract][Full Text] [Related]
29. Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.
Sorrentino VG; Thota S; Gonzalez EA; Rameshwar P; Chang VT; Etchegaray JP
Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358067
[TBL] [Abstract][Full Text] [Related]
30. MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer.
Wang WJ; Lai HY; Zhang F; Shen WJ; Chu PY; Liang HY; Liu YB; Wang JM
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34156978
[TBL] [Abstract][Full Text] [Related]
31. Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents.
Zhou Q; Sun X; Pasquier N; Jefferson P; Nguyen TTT; Siegelin MD; Angelastro JM; Greene LA
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065488
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast CEBPD/SDF4 axis in response to chemotherapy-induced angiogenesis through CXCR4.
Chi JY; Hsiao YW; Liu HL; Fan XJ; Wan XB; Liu TL; Hung SJ; Chen YT; Liang HY; Wang JM
Cell Death Discov; 2021 May; 7(1):94. PubMed ID: 33953165
[TBL] [Abstract][Full Text] [Related]
33. Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation.
Lai HY; Tsai HH; Yen CJ; Hung LY; Yang CC; Ho CH; Liang HY; Chen FW; Li CF; Wang JM
Front Cell Dev Biol; 2020; 8():596655. PubMed ID: 33681180
[TBL] [Abstract][Full Text] [Related]
34. Regulation of aromatase in cancer.
Molehin D; Rasha F; Rahman RL; Pruitt K
Mol Cell Biochem; 2021 Jun; 476(6):2449-2464. PubMed ID: 33599895
[TBL] [Abstract][Full Text] [Related]
35. CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.
Wang SM; Lin WC; Lin HY; Chen YL; Ko CY; Wang JM
Cell Death Discov; 2021 Jan; 7(1):8. PubMed ID: 33436575
[TBL] [Abstract][Full Text] [Related]
36. Licorice Ameliorates Cisplatin-Induced Hepatotoxicity Through Antiapoptosis, Antioxidative Stress, Anti-Inflammation, and Acceleration of Metabolism.
Man Q; Deng Y; Li P; Ma J; Yang Z; Yang X; Zhou Y; Yan X
Front Pharmacol; 2020; 11():563750. PubMed ID: 33240085
[TBL] [Abstract][Full Text] [Related]
37. SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD.
Wang D; Ruan X; Liu X; Xue Y; Shao L; Yang C; Zhu L; Yang Y; Li Z; Yu B; Feng T; Liu Y
Clin Transl Med; 2020 Sep; 10(5):e168. PubMed ID: 32997416
[TBL] [Abstract][Full Text] [Related]
38. Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.
Chen Y; Zhou H; Yang S; Su D
Cell Biochem Funct; 2021 Mar; 39(2):277-286. PubMed ID: 32815556
[TBL] [Abstract][Full Text] [Related]
39. Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model.
Lan XO; Wang HX; Qi RQ; Xu YY; Yu YJ; Yang Y; Guo H; Gao XH; Geng L
Mol Med Rep; 2020 Sep; 22(3):2263-2272. PubMed ID: 32705251
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
